Rino Rappuoli, Ph.D., is Chief Scientist and Head of External R&D at GSK Vaccines. His prior position was head of Vaccine R&D at Novartis. Dr. Rappuoli introduced many novel scientific concepts including genetic detoxification, cellular microbiology, reverse vaccinology and pangenome. He also developed licensed vaccines including acellular pertussis containing a non-toxic mutant of pertussis toxin; the first conjugate vaccine against meningococcus C; MF59, the first vaccine adjuvant after aluminium salts; meningococcus B; and CRM197, often used as carrier in conjugate vaccines. Dr. Rappuoli is the Founder of the GSK Vaccines Institute for Global Health (GVGH).
If you are a journalist looking to connect with this expert, please complete your contact information below. Your information will be sent to the expert and they will contact you if they are available. All fields, including media outlet, are required (except phone number).
Your request has been sent to the Immunization Advocates expert. If they are interested in serving as an expert resource, they will reach out to you directly. If you need assistance, please contact us at email@example.com.